RSS feed

Publications (original articles or review articles) published in 2024 from OUS - Department of Cardiology Ullevaal (Div Med)

67 publications found

Alehagen U, Alexander J, Aaseth JO, Larsson A, Opstad TB (2024)
Supplementation with selenium and coenzyme Q₁₀ in an elderly Swedish population low in selenium - positive effects on thyroid hormones, cardiovascular mortality, and quality of life
BMC Med, 22 (1), 191
DOI 10.1186/s12916-024-03411-1, PubMed 38714999

Alehagen U, Aaseth J, Schomburg L, Larsson A, Opstad T, Alexander J (2024)
Selenoprotein P increases upon selenium and coenzyme Q₁₀ supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality
Free Radic Biol Med, 222, 403-413
DOI 10.1016/j.freeradbiomed.2024.06.027, PubMed 38960007

Alrahimi J, Ahmed FA, Atar D (2024)
The Interplay of Atherothrombotic Factors and the Evolving Landscape of Atherosclerotic Cardiovascular Disease: Comprehensive Insights from Recent Studies
Anatol J Cardiol, 28 (8), 375-80 (in press)
DOI 10.14744/AnatolJCardiol.2024.4632, PubMed 39011832

Andel PM, Aamodt AH, Gleditsch J, Melin E, Rootwelt-Revheim ME, Steine K, Atar D (2024)
Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life
Cardiology, 149 (6), 571-579
DOI 10.1159/000540007, PubMed 39025051

Andrup S, Andersen GØ, Hoffmann P, Eritsland J, Seljeflot I, Halvorsen S, Vistnes M (2024)
Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality
PLoS One, 19 (5), e0302732
DOI 10.1371/journal.pone.0302732, PubMed 38739599

Atar D, Munkhaugen J, Sverre E (2024)
Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence?
Kardiol Pol, 82 (9), 828-830
DOI 10.33963/v.phj.102335, PubMed 39240921

Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, Larstorp ACK, Søraas CL, Rossebø AB, Rösner A, Grytaas MA, Gerdts E (2024)
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
High Blood Press Cardiovasc Prev, 31 (2), 157-166
DOI 10.1007/s40292-024-00632-6, PubMed 38530572

Aune SK, Helseth R, Kalstad AA, Laake K, Åkra S, Arnesen H, Solheim S, Seljeflot I (2024)
Links Between Adipose Tissue Gene Expression of Gut Leakage Markers, Circulating Levels, Anthropometrics, and Diet in Patients with Coronary Artery Disease
Diabetes Metab Syndr Obes, 17, 2177-2190
DOI 10.2147/DMSO.S438818, PubMed 38827167

Bergum H, Grimsmo J, Anderssen SA, Klemsdal TO (2024)
Effects on physical activity, physical fitness and well-being in a 36-months randomized controlled study, comparing a multimodal hospital-based intervention programme for primary cardiovascular prevention with usual care
BMC Cardiovasc Disord, 24 (1), 225
DOI 10.1186/s12872-024-03892-1, PubMed 38664620

Bondjers K, Glad AK, Wøien H, Wentzel-Larsen T, Atar D, Reitan SK, Rosseland LA, Zwart JA, Dyb G, Stensland SØ (2024)
Moral distress and protective work environment for healthcare workers during public health emergencies
BMC Med Ethics, 25 (1), 103
DOI 10.1186/s12910-024-01098-w, PubMed 39354454

Bonnevie-Svendsen M, Nyborg C, Bratseth V, Melau J, Hisdal J (2024)
Transient changes in L-arginine, asymmetric and symmetric dimethyl arginine in triathletes following Norseman Xtreme Triathlon
Front Physiol, 15, 1451038
DOI 10.3389/fphys.2024.1451038, PubMed 39493861

Bratseth V, Nendl A, Raju SC, Holm K, Broch K, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2024)
Gut dysbiosis and neutrophil extracellular traps in chronic heart failure
Int J Cardiol, 419, 132689
DOI 10.1016/j.ijcard.2024.132689, PubMed 39489348

Bratseth V, Watne LO, Neerland BE, Halaas NB, Pollmann CT, Karabeg A, Odegaard OT, Sydnes K, Zetterberg H, Seljeflot I, Helseth R (2024)
Increased cell-free DNA in CSF and serum of hip fracture patients with delirium
Brain Commun, 7 (1), fcae452
DOI 10.1093/braincomms/fcae452, PubMed 39737468

De Bortoli A, Nordøy I, Connelly JP, Viermyr HK, Bjerkreim RH, Broch K, Olsen PAS, Gude E, Fevang B, Jørgensen SF, Trøseid M, Steen T, Aukrust P, Andreassen AK, Skarpengland T (2024)
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohort
Int J Cardiol, 400, 131809
DOI 10.1016/j.ijcard.2024.131809, PubMed 38272129

Egan BM, Rich MW, Sutherland SE, Wright JT, Kjeldsen SE (2024)
General Principles, Etiologies, Evaluation, and Management in Older Adults
Clin Geriatr Med, 40 (4), 551-571
DOI 10.1016/j.cger.2024.04.008, PubMed 39349031

Enge K, Tveit A, Enger S, Onarheim S, Pripp AH, Rønningen PS, Solberg MG, Byrkjeland R, Andresen K, Halsen A, Aulie HA, Steinsvik T, Hall C, Ulimoen SR (2024)
Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 10 (6), 515-525
DOI 10.1093/ehjcvp/pvae032, PubMed 38702844

Engebretsen I, Bugge C, Støvring H, Husebye E, Sverre E, Dammen T, Halvorsen S, Munkhaugen J (2024)
Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event
Atherosclerosis, 393, 117550
DOI 10.1016/j.atherosclerosis.2024.117550, PubMed 38657552

Engebretsen I, Malene Ødegaard K, Halvorsen S, Bugge C, Kristiansen IS, Støvring H, Munkhaugen J (2024)
Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy
Eur Heart J Qual Care Clin Outcomes (in press)
DOI 10.1093/ehjqcco/qcae099, PubMed 39562279

Fadl Elmula FEM, Mariampillai JE, Heimark S, Kjeldsen SE, Burnier M (2024)
Medical Measures in Hypertensives Considered Resistant
Am J Hypertens, 37 (5), 307-317
DOI 10.1093/ajh/hpad118, PubMed 38124494

Falcão-Pires I, Ferreira AF, Trindade F, Bertrand L, Ciccarelli M, Visco V, Dawson D, Hamdani N, Van Laake LW, Lezoualc'h F, Linke WA, Lunde IG, Rainer PP, Abdellatif M, Van der Velden J, Cosentino N, Paldino A, Pompilio G, Zacchigna S, Heymans S, Thum T, Tocchetti CG (2024)
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
Eur J Heart Fail, 26 (7), 1454-1479
DOI 10.1002/ejhf.3264, PubMed 38837573

Fyksen TS, Seljeflot I, Vanberg P, Atar D, Halvorsen S (2024)
Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes
Thromb Res, 238, 60-66
DOI 10.1016/j.thromres.2024.04.027, PubMed 38676967

Gigante B, Tamargo J, Agewall S, Atar D, Ten Berg J, Campo G, Cerbai E, Christersson C, Dobrev D, Ferdinandy P, Geisler T, Gorog DA, Grove EL, Kaski JC, Rubboli A, Wassmann S, Wallen H, Rocca B (2024)
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
Eur Heart J Cardiovasc Pharmacother, 10 (7), 614-645
DOI 10.1093/ehjcvp/pvae064, PubMed 39237457

Gurholt TP, Elvsåshagen T, Bahrami S, Rahman Z, Shadrin A, Askeland-Gjerde DE, van der Meer D, Frei O, Kaufmann T, Sønderby IE, Halvorsen S, Westlye LT, Andreassen OA (2024)
Large-scale brainstem neuroimaging and genetic analyses provide new insights into the neuronal mechanisms of hypertension
HGG Adv, 6 (1), 100392
DOI 10.1016/j.xhgg.2024.100392, PubMed 39663699

Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Nienaber CA, Ray SG, Rossebø AB, Wachtell K, Dominguez H, Valeur N, Carstensen HG, Nielsen OW (2024)
Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwae086, PubMed 38416125

Halvorsen LV, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Liestøl K, Aune A, Olsen E, Brobak KM, Bergland OU, Rognstad S, Aarskog NR, Heimark S, Fadl Elmula FEM, Gerdts E, Mo R, Solbu MD, Opdal MS, Kjeldsen SE, Rostrup M, Høieggen A (2024)
Effect of Therapeutic Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial
Am J Hypertens, 37 (10), 826-836
DOI 10.1093/ajh/hpae059, PubMed 38713475

Halvorsen S, Hassager C (2024)
Cardiogenic shock in women: From risk factors to therapy
Kardiol Pol, 82 (11), 1071-1075
DOI 10.33963/v.phj.103739, PubMed 39737611

Halvorsen S, Vranckx P, van Diepen S (2024)
Should renin-angiotensin system inhibitors be stopped or not before non-cardiac surgery?
Eur Heart J Acute Cardiovasc Care, 13 (9), 670-671
DOI 10.1093/ehjacc/zuae101, PubMed 39257308

Holme FA, Huse C, Kong XY, Broch K, Gullestad L, Anstensrud AK, Andersen GØ, Amundsen BH, Kleveland O, Quiles-Jimenez A, Holm S, Aukrust P, Alseth I, Halvorsen B, Dahl TB (2024)
Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction
Int J Mol Sci, 25 (16)
DOI 10.3390/ijms25169014, PubMed 39201700

Jortveit J, Andersen GØ, Halvorsen S (2024)
Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: a nationwide cohort study 2013-22
Eur Heart J Acute Cardiovasc Care, 13 (12), 828-837
DOI 10.1093/ehjacc/zuae121, PubMed 39441985

Jortveit J, Boskovic M, Sandberg EL, Vegsundvåg J, Halvorsen S (2024)
High Diagnostic Accuracy of Long-Term Electrocardiogram Interpretation by General Practitioners
Int J Telemed Appl, 2024, 6624344
DOI 10.1155/2024/6624344, PubMed 38425473

Kindberg KM, Broch K, Andersen GØ, Anstensrud AK, Åkra S, Woxholt S, Tøllefsen IM, Ueland T, Amundsen BH, Kløw NE, Halvorsen B, Dahl TB, Huse C, Murphy SL, Damås JK, Opdahl A, Wiseth R, Gullestad L, Aukrust P, Santos-Gallego C, Seljeflot I, Stokke MK, Helseth R (2024)
Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size
JACC Adv, 3 (9), 101193
DOI 10.1016/j.jacadv.2024.101193, PubMed 39247678

Kristensen AMD, Munkhaugen J, Halvorsen S, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Lange T, Fagerland MW, Torp-Pedersen C, Prescott E, Atar D (2024)
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
Eur Heart J Cardiovasc Pharmacother, 10 (3), 175-183
DOI 10.1093/ehjcvp/pvad093, PubMed 38017624

Lambert AT, Sætre DO, Ratajczak-Tretel B, Gleditsch J, Høie G, Al-Ani R, Pesonen M, Atar D, Aamodt AH (2024)
Imaging features for the identification of atrial fibrillation in cryptogenic stroke patients
J Neurol, 271 (8), 5343-5356
DOI 10.1007/s00415-024-12397-y, PubMed 38904781

Langslet G, Nyström T, Vistisen D, Carstensen B, Grip ET, Casajust P, Tskhvarashvili G, Hoti F, Klement R, Karlsdotter K, Tuovinen M, Ofstad AP, Lajer M, Shay C, Koeneman L, Farsani SF, Niskanen L, Halvorsen S (2024)
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study
J Diabetes Res, 2024, 6142211
DOI 10.1155/2024/6142211, PubMed 39430801

Lopes RD, Granger CB, Wojdyla DM, McIntyre WF, Alings M, Mani T, Ramasundarahettige C, Rivard L, Atar D, Birnie DH, Boriani G, Amit G, Leong-Sit P, Rinne C, Duray GZ, Gold MR, Hohnloser SH, Kutyifa V, Benezet-Mazuecos J, Cosedis Nielsen J, Sticherling C, Benz AP, Linde C, Kautzner J, Mabo P et al. (2024)
Apixaban vs Aspirin According to CHA₂DS₂-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA
J Am Coll Cardiol, 84 (4), 354-364
DOI 10.1016/j.jacc.2024.05.002, PubMed 39019530

Lunde IG, Rypdal KB, Van Linthout S, Diez J, González A (2024)
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Matrix Biol, 134, 1-22
DOI 10.1016/j.matbio.2024.08.008, PubMed 39214156

Mancia G, Brunström M, Burnier M, Grassi G, Januszewicz A, Kjeldsen SE, Muiesan ML, Thomopoulos C, Tsioufis K, Kreutz R (2024)
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
Hypertension, 81 (5), 1021-1030
DOI 10.1161/HYPERTENSIONAHA.124.22821, PubMed 38477109

McClintick DJ, O'Donoghue ML, De Ferrari GM, Ferreira J, Ran X, Im K, López JAG, Elliott-Davey M, Wang B, Monsalvo ML, Atar D, Keech A, Giugliano RP, Sabatine MS (2024)
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
J Am Coll Cardiol, 83 (6), 652-664
DOI 10.1016/j.jacc.2023.11.029, PubMed 38325990

Mecinaj A, Gulati G, Omland T, Heck SL (2024)
Reply: Probing the Anthracycline-Induced Myocardial Injury: A Glimpse Through the Lens of the PRADA Trial
JACC CardioOncol, 6 (4), 630
DOI 10.1016/j.jaccao.2024.05.010, PubMed 39239351

Mecinaj A, Gulati G, Ree AH, Gravdehaug B, Røsjø H, Steine K, Wisløff T, Geisler J, Omland T, Heck SL (2024)
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction
JACC CardioOncol, 6 (1), 83-95
DOI 10.1016/j.jaccao.2023.10.008, PubMed 38510299

Melberg MB, Flaa A, Andersen GØ, Sunde K, Bellomo R, Eastwood G, Olasveengen TM, Qvigstad E (2024)
Effects of mild hypercapnia on myocardial injury after out-of-hospital cardiac arrest. A sub-study of the TAME trial
Resuscitation, 201, 110295
DOI 10.1016/j.resuscitation.2024.110295, PubMed 38936652

Narum M, Seljeflot I, Bratseth V, Berg TJ, Sveen KA (2024)
Intestinal fatty acid binding protein is associated with coronary artery disease in long-term type 1 diabetes-the Dialong study
Cardiovasc Diabetol, 23 (1), 419
DOI 10.1186/s12933-024-02509-3, PubMed 39563343

Nendl A, Andersen GØ, Seljeflot I, Trøseid M, Awoyemi A (2024)
Intestinal fatty acid binding protein is associated with infarct size and cardiac function in acute heart failure following myocardial infarction
Open Heart, 11 (2)
DOI 10.1136/openhrt-2024-002868, PubMed 39277188

Ni W, Stafoggia M, Zhang S, Ljungman P, Breitner S, Bont J, Jernberg T, Atar D, Agewall S, Schneider A (2024)
Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden
J Am Coll Cardiol, 84 (13), 1149-1159
DOI 10.1016/j.jacc.2024.07.006, PubMed 39230547

Nordén ES, Bendiksen BA, Bergo KK, Espe EKS, McGinley G, Hasic A, Hauge-Iversen IM, Ugland HK, Shen X, Frisk M, Mabotuwana NS, Louch WE, Hussain RI, Zhang L, Sjaastad I, Cataliotti A, Christensen G (2024)
Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats
ESC Heart Fail (in press)
DOI 10.1002/ehf2.15145, PubMed 39696842

Nordlund D, Lav T, Jablonowski R, Khoshnood A, Ekelund U, Atar D, Erlinge D, Engblom H, Arheden H (2024)
Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using CMR-derived pressure-volume loop data
Clin Cardiol, 47 (1), e24216
DOI 10.1002/clc.24216, PubMed 38269628

Olsen E, Jamerson K, Schmieder RE, Søraas CL, Mariampillai JE, Mancia G, Kjeldsen SE, Heimark S, Mehlum MH, Liestøl K, Larstorp ACK, Halvorsen LV, Høieggen A, Burnier M, Rostrup M, Julius S, Weber MA (2024)
Effects of valsartan vs amlodipine and achieved lower blood pressure on the incidence of end-stage kidney disease: The VALUE Trial
Eur J Intern Med, 133, 55-63
DOI 10.1016/j.ejim.2024.12.021, PubMed 39694747

Olsen MB, Louwe MC, Yang K, Øgaard J, Dahl TB, Gregersen I, Alfsnes K, Lauritzen KH, Murphy SL, Ahmed MS, Aukrust P, Vinge LE, Yndestad A, Holven KB, Halvorsen B, Fosshaug LE (2024)
Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling
Biochem Biophys Res Commun, 733, 150706
DOI 10.1016/j.bbrc.2024.150706, PubMed 39305571

Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024)
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
Genome Med, 16 (1), 27
DOI 10.1186/s13073-024-01296-6, PubMed 38331891

Rubboli A, Atar D, Sibbing D (2024)
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigm
Intern Emerg Med, 19 (6), 1537-1548
DOI 10.1007/s11739-024-03590-y, PubMed 38594458

Rypdal KB, Apte SS, Lunde IG (2024)
Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment
Mol Biol Rep, 51 (1), 280
DOI 10.1007/s11033-024-09255-5, PubMed 38324186

Sambola A, Halvorsen S, Adlam D, Hassager C, Price S, Rosano G, Schiele F, Holmvang L, de Riva M, Rakisheva A, Sulzgruber P, Swahn E (2024)
Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Open, 4 (2), oeae011
DOI 10.1093/ehjopen/oeae011, PubMed 38628674

Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Grenne BL, Jortveit J (2024)
Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial
Int J Telemed Appl, 2024, 4080415
DOI 10.1155/2024/4080415, PubMed 38567031

Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Leangen Grenne B, Jortveit J (2024)
Digital recruitment and compliance to treatment recommendations in the Norwegian Atrial Fibrillation self-screening pilot study
Eur Heart J Digit Health, 5 (3), 371-378
DOI 10.1093/ehjdh/ztae026, PubMed 38774377

Schlotter F, Huber K, Hassager C, Halvorsen S, Vranckx P, Pöss J, Krychtiuk K, Lorusso R, Bonaros N, Calvert PA, Montorfano M, Thiele H (2024)
Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery
Eur Heart J, 45 (28), 2478-2492
DOI 10.1093/eurheartj/ehae363, PubMed 38888906

Schnabel RB, Benezet-Mazuecos J, Becher N, McIntyre WF, Fierenz A, Lee SF, Goette A, Atar D, Bertaglia E, Benz AP, Chlouverakis G, Birnie DH, Dichtl W, Blomstrom-Lundqvist C, Camm AJ, Erath JW, Simantirakis E, Kutyifa V, Lip GYH, Mabo P, Marijon E, Rivard L, Schotten U, Alings M, Sehner S et al. (2024)
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials
Eur Heart J, 45 (46), 4902-4916
DOI 10.1093/eurheartj/ehae596, PubMed 39222018

Sevre K, Rist A, Wachtell K, Devereux RB, Aurigemma GP, Smiseth OA, Kjeldsen SE, Julius S, Pitt B, Burnier M, Kreutz R, Oparil S, Mancia G, Zannad F (2024)
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence
Am J Hypertens, 37 (1), 1-14
DOI 10.1093/ajh/hpad073, PubMed 37551929

Skjøth F, Larsen TB, Dun AR, Lilja M, Rahman I, Abdelgawwad K, Halvorsen S, Coleman C, Rivera M (2024)
Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Am J Med, 137 (6), 520-528.e13
DOI 10.1016/j.amjmed.2024.02.005, PubMed 38387539

Sternberg Z, Podolsky R, Yu J, Hua S, Halvorsen S, Hojnacki D, Schaller BJ (2024)
Anti-Hypertensives Reduce the Rate of Alzheimer's Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses
J Prev Alzheimers Dis, 11 (6), 1634-1646
DOI 10.14283/jpad.2024.156, PubMed 39559876

Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG et al. (2024)
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
Eur J Heart Fail, 26 (10), 2055-2076
DOI 10.1002/ejhf.3340, PubMed 39087551

Tsaban G, Perez RV, Krychtiuk KA, Ahrens I, Halvorsen S, Hassager C, Huber K, Schiele F, Sionis A, Claeys MJ (2024)
Lipid-lowering therapy after acute coronary syndromes: a multinational European survey
Coron Artery Dis, 36 (1), 51-58
DOI 10.1097/MCA.0000000000001420, PubMed 39263716

Vistnes M (2024)
Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
Pharmaceuticals (Basel), 17 (3)
DOI 10.3390/ph17030267, PubMed 38543053

Vrsalovic M, Heimark S, Søraas CL, Mehlum MH, Kjeldsen SE, Mancia G, Julius S, Weber MA (2024)
Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial
Hypertension, 81 (7), 1628-1636
DOI 10.1161/HYPERTENSIONAHA.124.22832, PubMed 38716657

Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Damås JK, Kleveland O (2024)
Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI
Int J Cardiol, 418, 132613
DOI 10.1016/j.ijcard.2024.132613, PubMed 39374793

Xiong W, Agewall S, Yamashita Y (2024)
Anticoagulation in cancer-associated thrombosis: how long should the therapy be?
Eur Heart J Cardiovasc Pharmacother, 10 (1), 3-4
DOI 10.1093/ehjcvp/pvad075, PubMed 37827545

Zimerman A, O'Donoghue ML, Ran X, Im K, Ott BR, Mach F, Zavitz K, Kurtz CE, Monsalvo ML, Wang B, Atar D, Keech A, Sabatine MS, Giugliano RP (2024)
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab
NEJM Evid, 4 (1), EVIDoa2400112
DOI 10.1056/EVIDoa2400112, PubMed 39718423

Aaseth E, Christiansen JR (2024)
Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
ESC Heart Fail, 11 (2), 871-876
DOI 10.1002/ehf2.14645, PubMed 38204282